CERo Therapeutics Holdings, Inc.
OTCPKCERO, the micro-cap biotech trading on OTC markets at $0.027, heads into the back half of May with a dramatic-looking short interest jump that almost entirely dissolves under closer inspection. The headline number is striking: short interest climbed roughly 1,400% over the past week, rising from fewer than 9,000 shares to around 112,000 shares short. But context matters here…
Snapshot as of 16 May 2026
CERO, the micro-cap biotech trading on OTC markets at $0.027, heads into the back half of May with a dramatic-looking short interest jump that almost entirely dissolves under closer inspection. The headline number is…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CERO — free to start on ORTEX.
Sign up for free →Open CERO on ORTEX